Pharmaceutical Technology

SEPTEMBER 1, 2022

In the pursuit of improving patient care, the continued development of POC testing can help support future demand for rapid diagnosis and treatment, with opportunities to implement successful POC facilities expanding over the years as the technology has improved. To compose one full molecular device, there are many, many components.”. “The

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

Drug Discovery World

JANUARY 30, 2024

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

pharmaphorum

DECEMBER 16, 2022

Dopavision, a DTx company in the eye health space, has brought on ophthalmology and neuroscience expert Dirk Sauer , a veteran of Novartis Pharma, to advise the company as it continues to develop MyopiaX, a digital therapeutic for childhood myopia control. AI and robotics hires. McKinnell, Jr. to support the company’s growth.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Drug Discovery World

MAY 16, 2023

Skills gap Bruce Levine, International Society for Cell & Gene Therapy (ISCT) Immediate Past President and Chair, Strategic Advisory Council, says a critical challenge that has become apparent for the CGT sector is the need for workforce development and training resources. Clinical endpoints are no longer the only things that matter.

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

The Pharma Data

OCTOBER 14, 2020

A paper on the clinical trial results published in JAMA Oncology demonstrates the effectiveness of Savran Tech’s CTC detection technology with real world patients. BOSTON–( BUSINESS WIRE )– Savran Technologies Inc., BOSTON–( BUSINESS WIRE )– Savran Technologies Inc., About This Clinical Trial.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Genome 40

Drug Discovery World

DECEMBER 23, 2022

The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials. BRL-201 was developed using Quikin CART, BRL’s non-viral site-specific integration platform, which can produce CAR-T cell products using one-step, non-viral preparation. .

Gene Therapy 52

Gene Therapy Gene Reagent Clinical Trials 52

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E.

Antibody 59

Antibody Protein Engineer In-Vivo 59